LBT Innovations (ASX:LBT) - Chair Elect Joanne Moss
Chair Elect Joanne Moss
Source: Ellume
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • LBT Innovations (LBT) appoints Joanne Moss as the company’s new Chair-Elect as it looks to rejuvenate its board
  • Ms Moss will begin working for LBT as a Non-Executive Director before moving into the Chair role later this year
  • The company says the new leader brings experience in US commercialisation, deal strategy, scale-up and capital raising to the role
  • While current Chair Kate Costello welcomed the appointment and says she will retire after helping support the transition
  • LBT shares are up 5.26 per cent at 8 cents per share

LBT Innovations (LBT) has appointed Joanne Moss as the company’s new Chair-Elect as it looks to rejuvenate its board.

The healthcare stock announced the news on Thursday, revealing Ms Moss would first begin working for LBT as a Non-Executive Director.

The company said she’ll then move into the Independent Chair role in September this year, when outgoing Chair Kate Costello retires.

Ms Moss currently works as a Non-Executive Director of Ellume — a digital diagnostic company that works in partnership with GSK, Qiagen and the US Government.

LBT said the new leader’s experience in US commercialisation, deal strategy, scale-up and capital raising would prove very useful for the business as it continues to sell its technology in the region.

Commenting on the new role, Ms Moss said she was excited to be joining LBT.

“LBT is an example of Australian innovation at its finest and I am delighted to join the team,” Ms Moss said.

“LBT is in the early stages of global commercialisation of its ground-breaking technology and I very much look forward to sharing my knowledge and
experience to help fast track LBT’s future growth and success.”

Meanwhile, Ms Costello said she was pleased to see Ms Moss replace her and would help provide a succesful transition.

“Joanne has a deep understanding of the commercial pressures facing technology focused organisations and the challenges associated with scale-up and global commercialisation,” Ms Costello said.

“We are thrilled to have Joanne join our board and I am personally looking forward to working alongside her as she transitions to the role of Chair of the company.”

LBT Innovations ended Thursday trading up 5.26 per cent at 8 cents per share.

LBT by the numbers
More From The Market Online

ResMed spikes on robust results and global growth spurt

ResMed shares have climbed following the release of the company's strong Third Quarter FY2024 results.

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Recce wins safety board approval to dose 4g in R327 UTI infusion trial

Recce Pharma will dose patients with 4g of its R327 intravenous solution to treat UTIs in…

Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M

WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…